Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

The head of drugmaker Eli Lilly, which sells the popular weight ... right mechanism” to bolster U.S. drug manufacturing, Lilly Chief Executive David Ricks said on a conference call with analysts ...

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced executive leadership ... "With these changes, we will create the additional focus we need to reach ...

Eli Lilly and Co. on Thursday announced three executive leadership transitions that the Indianapolis drugmaker said better ...

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that ... Ricks, Lilly's chair and CEO. "With these changes, we will create ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Just as Eli Lilly appeared ... In essence, the formulary change is likely to boost access to Wegovy in the U.S., though potentially at the expense of that for Lilly’s Zepbound.

LONDON/COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President ...

Eli Lilly & Co. plans to manufacture its new weight ... “We’re going to make this medicine here in the United States,” Chief Executive Officer Dave Ricks said Friday in an interview with ...